These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9773872)

  • 1. Quantitation of CD38 activation antigen expression on CD8+ T cells in HIV-1 infection using CD4 expression on CD4+ T lymphocytes as a biological calibrator.
    Hultin LE; Matud JL; Giorgi JV
    Cytometry; 1998 Oct; 33(2):123-32. PubMed ID: 9773872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of CD38 expression using QuantiBRITE beads.
    Iyer SB; Hultin LE; Zawadzki JA; Davis KA; Giorgi JV
    Cytometry; 1998 Oct; 33(2):206-12. PubMed ID: 9773881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression.
    Liu Z; Cumberland WG; Hultin LE; Prince HE; Detels R; Giorgi JV
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Oct; 16(2):83-92. PubMed ID: 9358102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indicators of T-cell activation: correlation between quantitative CD38 expression and soluble CD8 levels in asymptomatic HIV+ individuals and healthy controls.
    Lenkei R; Bratt G; Holmberg V; Muirhead K; Sandström E
    Cytometry; 1998 Oct; 33(2):115-22. PubMed ID: 9773871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multisite comparison of methods for the quantitation of the surface expression of CD38 on CD8(+) T lymphocytes. The ACTG Advanced Flow Cytometry Focus Group.
    Schmitz JL; Czerniewski MA; Edinger M; Plaeger S; Gelman R; Wilkening CL; Zawadzki JA; Wormsley SB
    Cytometry; 2000 Jun; 42(3):174-9. PubMed ID: 10861690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface antigen detection with non-fluorescent, antibody-coated microbeads: an alternative method compatible with conventional fluorochrome-based labeling.
    Fortin M; Hugo P
    Cytometry; 1999 May; 36(1):27-35. PubMed ID: 10331624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic analysis of CD8+ T lymphocytes in a cohort of HIV type 1-infected patients treated with saquinavir, ritonavir, and two nucleoside analogs for 1 year, and association with plasma HIV type 1 RNA.
    Kaufmann GR; Zaunders JJ; Cunningham P; Cooper DA
    AIDS Res Hum Retroviruses; 1999 Jul; 15(11):963-72. PubMed ID: 10445808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD38 expression on CD8(+) T cells as a prognostic marker in vertically HIV-infected pediatric patients.
    Sherman GG; Scott LE; Galpin JS; Kuhn L; Tiemessen CT; Simmank K; Meddows-Taylor S; Meyers TM
    Pediatr Res; 2002 Jun; 51(6):740-5. PubMed ID: 12032270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential susceptibility of resting CD4(+) T lymphocytes to a T-tropic and a macrophage (M)-tropic human immunodeficiency virus type 1 is associated with their surface expression of CD38 molecules.
    Horikoshi H; Kinomoto M; Sasao F; Mukai T; Luftig RB; Ikuta K
    Virus Res; 2001 Jan; 73(1):1-16. PubMed ID: 11163640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CD28 and CD38 by CD8+ T lymphocytes in HIV-1 infection correlates with markers of disease severity and changes towards normalization under treatment. The Swiss HIV Cohort Study.
    Bürgisser P; Hammann C; Kaufmann D; Battegay M; Rutschmann OT
    Clin Exp Immunol; 1999 Mar; 115(3):458-63. PubMed ID: 10193418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated relative fluorescence intensity of CD38 antigen expression on CD8+ T cells is a marker of poor prognosis in HIV infection: results of 6 years of follow-up.
    Liu Z; Hultin LE; Cumberland WG; Hultin P; Schmid I; Matud JL; Detels R; Giorgi JV
    Cytometry; 1996 Mar; 26(1):1-7. PubMed ID: 8809474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD38 expression on cryopreserved CD8+ T cells predicts HIV disease progression.
    Perfetto SP; Malone JD; Hawkes C; McCrary G; August B; Zhou S; Garner R; Dolan MJ; Brown AE
    Cytometry; 1998 Oct; 33(2):133-7. PubMed ID: 9773873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency.
    Liu Z; Cumberland WG; Hultin LE; Kaplan AH; Detels R; Giorgi JV
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(4):332-40. PubMed ID: 9704938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients.
    Bofill M; Mocroft A; Lipman M; Medina E; Borthwick NJ; Sabin CA; Timms A; Winter M; Baptista L; Johnson MA; Lee CA; Phillips AN; Janossy G
    AIDS; 1996 Jul; 10(8):827-34. PubMed ID: 8828739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study.
    Giorgi JV; Liu Z; Hultin LE; Cumberland WG; Hennessey K; Detels R
    J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):904-12. PubMed ID: 7686224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1-specific cytolytic T-lymphocyte activity correlates with lower viral load, higher CD4 count, and CD8+CD38-DR- phenotype: comparison of statistical methods for measurement.
    Lubaki NM; Shepherd ME; Brookmeyer RS; Hon H; Quinn TC; Kashamuka M; Johnson M; Gottle R; Devers J; Lederman HM; Bollinger RC
    J Acquir Immune Defic Syndr; 1999 Sep; 22(1):19-30. PubMed ID: 10534143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different meaning of CD38 molecule expression on CD4+ and CD8+ cells of children perinatally infected with human immunodeficiency virus type 1 infection surviving longer than five years.
    de Martino M; Rossi ME; Azzari C; Gelli MG; Galli L; Vierucci A
    Pediatr Res; 1998 Jun; 43(6):752-8. PubMed ID: 9621984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation and cell cycle antigens in CD4+ and CD8+ T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection.
    Orendi JM; Bloem AC; Borleffs JC; Wijnholds FJ; de Vos NM; Nottet HS; Visser MR; Snippe H; Verhoef J; Boucher CA
    J Infect Dis; 1998 Nov; 178(5):1279-87. PubMed ID: 9780247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. During HIV infection, CD4+ CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose V beta repertoire is similar to that of CD4+ CD38- T-cells.
    Ramzaoui S; Jouen-Beades F; Gilbert D; Borsa-Lebas F; Michel Y; Humbert G; Tron F
    Clin Immunol Immunopathol; 1995 Oct; 77(1):33-41. PubMed ID: 7554481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection.
    Kestens L; Vanham G; Vereecken C; Vandenbruaene M; Vercauteren G; Colebunders RL; Gigase PL
    Clin Exp Immunol; 1994 Mar; 95(3):436-41. PubMed ID: 7907956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.